Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of prophylactic antibiotics for pancreatoduodenectomy with endoscopic biliary stenting
jRCTs041220033Active, not recruiting
- Start
- Jul 2022
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in pancreatic cancer (PC), Periampullary Carcinoma and biliary obstruction comparing Cefazolin prophylaxis with Ceftriaxone prophylaxis (2 arms). Primary endpoint: Incidence of surgical site infection (SSI). Started Jul 2022; status: active, not recruiting.
02
Drugs
cefazolinceftriaxone
03
Conditions
pancreatic cancer (PC)Periampullary Carcinomabiliary obstruction
Beyond the preview
Go deeper on jRCTs041220033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220033.